Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
15.13M
Enterprise Value
11.41M
Income
-32.16M
Sales
30.18M
Book/sh
2.68
Cash/sh
0.88
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
97
IPO
Sep 21, 2018
P/E
-
Forward P/E
-
PEG
-
P/S
0.50
P/B
0.48
P/C
1.45
P/FCF
-
EV/EBITDA
-
EV/Sales
0.38
Quick Ratio
1.96
Current Ratio
2.48
Debt/Eq
0.21
LT Debt/Eq
0.18
Option/Short
No / Yes
EPS (ttm)
-3.73
EPS next Y
-0.97
EPS next Q
-0.45
EPS this Y
67.10%
EPS next Y
54.67%
EPS next 5Y
56.92%
EPS past 3/5Y
73.98% 54.05%
Sales past 3/5Y
0.84% 27.37%
EPS Y/Y TTM
91.68%
Sales Y/Y TTM
10.03%
EPS Q/Q
67.74%
Sales Q/Q
21.36%
Insider Own
5.93%
Insider Trans
1.16%
Inst Own
20.24%
Inst Trans
-1.36%
ROA
-52.04%
ROE
-83.56%
ROIC
-85.92%
Gross Margin
47.50%
Oper. Margin
-106.67%
Profit Margin
-106.58%
SMA20
-10.22%
SMA50
-6.77%
SMA200
2.39%
Trades
Shs Outstand
11.78M
Shs Float
11.08M
52W High
2.23 -42.38%
52W Low
1.00 28.50%
Volatility
6.73% 6.81%
ATR (14)
0.10
RSI (14)
40.14
Beta
1.70
Rel Volume
0.12
Avg Volume
926.94K
Volume
30,344
Perf Week
-6.20%
Perf Month
-24.41%
Perf Quarter
15.77%
Perf Half Y
6.20%
Perf YTD
-16.01%
Perf Year
-33.07%
Perf 3Y
-98.67%
Perf 5Y
-99.96%
Perf 10Y
-
Prev Close
1.25
Price
1.28
Change %
2.80%
Date Action Analyst Rating Change Price Target Change
Nov-15-24Downgrade Ladenburg Thalmann Buy → Neutral
Sep-10-24Downgrade BTIG Research Buy → Neutral
Jan-05-23Initiated Scotiabank Sector Outperform $4
Dec-12-22Resumed BTIG Research Buy $3.50
Jul-18-22Resumed Oppenheimer Outperform $12
Jun-16-21Initiated BTIG Research Buy $10
Sep-24-20Initiated Ladenburg Thalmann Buy $1.25
Apr-08-20Initiated Oppenheimer Outperform $1.50
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Luderer AlbertInterim Chief ExecutiveSep 04 '26Buy1.214,0004,8458,000Sep 09 04:30 PM
Luderer AlbertInterim Chief ExecutiveAug 21 '26Buy1.224,0004,8604,000Aug 21 04:30 PM
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
ChairmanDr. Albert A. Luderer Ph.D.
Chief Operating OfficerMr. Mark Oldakowski
Chief Accounting OfficerMr. Mark Adamchak CPA
Chief Scientific OfficerDr. Alex Hastie Ph.D.
Chief Legal Officer & Corporate SecretaryMr. Jonathan Dixon J.D.